A Comparative Evaluation of Drops versus Atomized Administration of Intranasal Ketamine for the Procedural Sedation of Young Uncooperative Pediatric Dental Patients: A Prospective Crossover Trial

Objective: The objective of this study was to compare and evaluate the efficacy and safety of drops and atomized administration of intranasal ketamine (INK) in terms of behavioral response for agent acceptance during administration and for agent efficacy and safety for the sedation of young uncooperative pediatric dental patients. Study design: Thirty Four uncooperative ASA grade-1 children, requiring dental treatment were randomly assigned to receive INK as drops and atomized spray in one of the subsequent visit. This was a two stage cross-over trial and each child received INK by both modes of administration. The vital signs were monitored continuously during each visit. Results: A statistically significant difference in patients acceptance (P<0.0001) was observed in the atomized administration when compared to drops administration for the procedural event of drug administration. Moreover, there were also significant differences(P<0.05) between onset of sedation and recovery time between two groups. All the vital signs were within normal physiological limits and there were no significant adverse effects in either group. Conclusions: INK is safe and effective by either mode of intranasal (IN) drug administration for moderate sedation in facilitating dental care for anxious and uncooperative pediatric dental patients. Moreover, INK when administered with the mucosal atomization device, the acceptance of the drug was associated with less aversive reaction, rapid onset and recovery of sedation, as compared to the drop administration of the same agent.

Moderate sedation, intranasal ketamine, intranasal drops and spray

1. Krauss B, editor. Pediatric procedural sedation and analgesia. Philadel-phia: Lippincott Williams and Wilkins; 1999.

2. Krauss B, Green S. Sedation and analgesia for procedures in children. N Engl J Med, 342: 938–45, 2000.

3. Kaplan RF, Yang CI. Sedation and analgesia in pediatric patients for procedures outside the operating room. Anesthesiol Clin North Amer-ica, 20(1): 181–94, 2002.

4. Pitetti RD, Singh S, Pierce MC. Safe and efficacious use of procedural sedation  and  analgesia  by  non-anesthesiologists  in  a  pediatric  emer-gency department. Arch Pediatr Adolesc Med, 157(11): 1090–6, 2003.

5. Doyle L, Colletti JE. Pediatric procedural sedation and analgesia. Pedi-atr Clin North Am, 53(2): 279–92, 2006.

6. Padmanabhan MN, Pande RK, Saksena AK, Chandra G. A comparative evaluation  of  agents  producing  Analgo-sedation  in  pediatric  dental patients. Journal of Clinical Pediatric Dentistry, 34(2): 183–189, 2009.

7. Wilton NC, Leigh J, Rosen DR, Pandit UA. Pre-anesthetic sedation of preschool  children  using  intranasal  midazolam,  Anesthesiology,  69: 972–975, 1988.

8. Saint–Maurice  C,  Landias  A,  Delleur  MM,  Esteve  C,  MacGee  K, Murat I. The use of midazolam in diagnostic and short surgical proce-dures in children. Acta Anesthesiol Scand Suppl, 92: 39, 1990.

9. Lee-Kim SJ, Fadavi S, Punwani I, Koerber A. Nasal Versus oral mida-zolam sedation for pediatric dental patients. J dent child (chic), May-Aug, 71(2): 135–138, 2004.

10. Henry RJ, Ruano N, Casto D, Wolf RH. A pharmacokinetic study of midazolam  in  dogs:  nasal  drop  vs.  atomizer  administration.  Pediatr Dent, 20: 321–6, 1998.

11. Timothi R. Wolfe and Tony B. Intranasal drug delivery: An Alternative to Intravenous Administration in Selected Emergency Cases. Journal of Emergency Nursing, April 30: 2: 141–47, 2004

12. Lochary ME, Wilson S, Griffen AL, et al. Temperament as a predictor of  behavior  for  conscious  sedation  in  dentistry.  Pediatr  Dent,  15: 348–352, 1993.

13. Singh N, Pandey RK, Saksena AK, Jaiswal JN. A comparative evalua-tion of oral midazolam with other sedative as premedication in pedi-atric dentistry. J Clin Pediatr Dent, 26(2): 161–164, 2002.

14. Koirala B, Pandey RK, Saksena AK, Kumar R, Sharma S. A compara-tive  evaluation  of  newer  sedatives  in  conscious  sedation.  Journal  of Clinical Pediatric Dentistry, 30: 273–276, 2006.

15. Bahetwar  SK,  Pandey  RK,  Saksena AK,  Chandra  G. A  comparative evaluation  of  intranasal  midazolam,  ketamine  and  their  combination for sedation of young uncooperative pediatric dental patients: a triple blind randomized crossover trial. Accepted for publication. Journal of Clinical Pediatric Dentistry, 2011

16. American  Academy  of  Pediatrics;  American  Academy  of  Pediatric Dentistry, Coté CJ. Wilson S. Work Group on Sedation. Guidelines for monitoring and management of pediatric patients during and after seda-tion for diagnostic and therapeutic procedures: an update. Pediatr, Jan 118(6): 2587–602, 2006.

17. Citerio G, Franzosi MG, Latini R. Anaesthesiological strategies in elec-tive craniotomy: randomized, equivalence, open trial- the NeuroMor-feo trial. Trials, Apr10: 19, 2009.

18. McCarty EC, Mencio GA, Walker LA, Green NE. Ketamine sedation for the reduction of children’s fractures in the emergency department. J Bone Joint Surg Am, 82-A: 912–18, 2000.

19. Reich DL, Silvay G. Ketamine on the first twenty five years of clinical experience. Can J Anaesth, 36: 186–97, 1989.

20. Green SM, Krauss B. The semantics of ketamine. Ann Emerg Med, 36: 480–2, 2000.

21. Kennedy RM, porter FL, Miller JP et al. Comparison of fentanyl/mida-zolam with ketamine /midazolam for pediatric orthopedic emergencies. Pediatrics, 102: 956–63, 1998.

22. McGlone R, Fleet T, Durham S, Hollis S. A comparison of intramuscu-lar ketamine with high dose intramuscular midazolam with and without intranasal  flumazenil  in  children  before  suturing.  Emerg  Med  J,  18: 34–8, 2001.

23. Green SM, Rothrock SG, Lynch EL et al. Intramuscular ketamine for pediatric sedation in the emergency department: Safety profile in 1022 cases. Ann Emerg Med, 31: 688–97, 1998.

24. Dachs  RJ,  Innes  GM.  Intravenous  ketamine  sedation  of  pediatric patients in the emergency department. Ann Emerg Med, 29: 146–50, 1997.

25. Green SM, Clark R, Hostetler MA et al. Inadvertent Ketamine overdose in children; Clinical menifestations and outcome. Ann Emerg Med, 34: 492–7, 1999.

26. Holloway VJ, Husain HM, Saetta JP, Gautam V. Accident and emer-gency department led implementation of ketamine sedation in pediatric practice and parental response. J Accid Emerg Med, 17: 25–8, 2000.

27. Priestley SJ, Taylor J, McAdam CM, Francis P. Ketamine sedation for children in the emergency department. Emerg Med, 13: 82–90, 2001.

28. Wilson S, Farrell K, griffen A, et al. Conscious sedation experiences in graduate pediatric dentistry programs. Pediatr Dent, 23: 307–14, 2001.

29. Kain  ZN,  Mayes  LC.  Anxiety  in  children  during  the  peri-operative period.  In  Bamstein  M,  Gennevro  J  (eds):  Child  Development  and Behavioral  Pediatrics.  Mahwah  NJ,  Lawrence  Erlbaum  Associates, 85–103, 1996.

30. Hanson DJ. Intramuscular injection: Injuries and complications. Gen Pract, 27: 109–12, 1963.

31. Sarkar MA. Drug metabolism in the nasal mucosa. Pharmaceutic Res, 9: 1–3, 1992.

32. Al-Rakaf H, Bello LL, Turkustani A, Adenubi JO. Intranasal midazo-lam in conscious sedation of young paediatric dental patients. Int J Pae-diatr Dent, 11(1): 33–40, 2001.

33. Mazaheri  R,  Eshghi  A,  Bashardoost  N,  Kavyani  N.  Assessment  of intranasal  midazolam  administration  with  a  dose  of  0.5  mg/kg  in behavior management of uncooperative children. J Clin Pediatr Dent, 32(2): 95–99, 2007.

34. Fukata O, Braham RL, Yanase H, Kurosu K.  The sedative effect of intranasal midazolam administration in the dental treatment of patients with  mental  disabilities.  Part  2:  optimal  concentration  of  intranasal midazolam. J Clin Pediatr Dent, 18(4): 259–65, 1994.

35. Fuks A., Kaufman E., Ram D., Hovav S. Shapira J. Assessment of two doses of intranasal midazolam for sedation of young pediatric dental patient. Pediatr Dent, 16: 301, 1994. 

36. Roelofse  JA,  Shipton  EA,  De  La  Harpe  CJ,  Blignaut  RJ.  Intranasal sufentanil  /  Midazolam  Versus  Ketamine/Midazolam  for analgesia/sedation in the pediatric population prior to undergoing mul-tiple dental extractions under general anesthesia: A prospective, dou-ble-blind, randomized comparison. Anesth Prog, 51: 114–121, 2004.

37. Primosch RE, Guelmann Marcio. Comparison of Drops Versus Spray Administration  of  Intranasal  Midazolam  in  Two-and  Three-year  old Children for Dental Sedation. Pediatr Dent, 27:5: 401–8, 2005.

38. Gharde  P,  Chauhan  S,  Kiran  U.  Evaluation  of  Efficacy  of  intranasal Midazolam, Ketamine and their Mixture as premedication and its rela-tion with bispectral index in children with tetralogy of fallot undergo-ing intracardiac repair. Ann Card Anaesth, 9: 25–30, 2006.

39. Gutstein HB, Johnson KL, Heard MB, Gregory GA. Oral ketamine pre-anesthetic medication in children. Anesthesiology, 76: 28–33, 1992.

40. Roelofse JA. The evolution of ketamine applications in children. Pedi-atric Anesthesia, 20: 240–45, 2010.

41. Bui T, Redden RJ, Murphy S.  A comparasion study between Ketamine and Ketamine-promethazine combination for oral sedation in pediatric dental patients. Anaesth Prog, 49(1): 14–18, 2002.

42. Damle SG, Gandhi M, Laheri V. Comparision of oral ketamine and oral midazolam  as  a  sedative  agent  in  pediatric  dentistry.  J  Indian  Soc Pedod Prev Dent, 26(3): 97–101, 2008.

43. Alfonzo-Echeverri EC, Berg JH, Wild TW, Glass NC. Oral ketamine foe pediatric outpatient dental surgery sedation. Pediatr Dent, 15: 182-185, 1993.

44. Petros AJ. Oral ketamine its use foe mentally retarded adults requiring day care dental treatment. Anaesthesia, 46: 646–47, 1991.

45. Rosenberg M. Oral ketamine for deep sedation of difficult to manage children who are mentally handicapped: case report. Pediatr Dent, 13: 221–23, 1991.

46. Moore  PA,  Mickey  EA,  Hargroves  JA,  Needleman  HI.  Sedation  in pediatric dentistry: a practical assessment procedure. J Am Dent Assoc, 109: 564–69, 1984. 

47. Griffith N, Howell S, Mason DG. Intranasal midazolam for premedica-tion of children undergoing day-case anaesthesia: Comparison of two delivery  systems  with  assessment  of  intra-observer  variability.  Br  J Anaesth, 81: 865–69, 1998.

48. Ljungman G, Krueger A, Andreasson S, et al. Midazolam nasal spray reduces procedural anxiety in children. Pediatrics, 105: 73–78, 2000.

49. Thum P, Heine J, Hollenhorst J, et al. Midazolam given as an intranasal spray in children. Br J Anaesth, 81: 100–01, 1998.

50. Gudmundsdottir  H,  Sigurjonsdottir  J,  Masson  M,  et  al.  Intranasal administration  of  midazolam  in  a  cyclodextrin  based  formulation: Bioavailability  and  clinical  evaluation  in  humans.  Pharmazie,  56: 963–66, 2001.

51. Hannallah  R.S.  and  Patel  R.I.  Low  dose  intramuscular  ketamine  for anesthesia preinduction in young children undergoing brief outpatient procedures. Anesthesiology, 70: 598–600, 1989. 

52. Hollister  G.R.  and  Burn  JNB.  Side  effects  of  ketamine  in  pediatric anesthesia. Anesth Analg, 53: 264–7, 1974.